Needham Keeps Buy Rating on CompoSecure and Increases Price Target to $22
Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders, helping them stay informed and make timely decisions in the stock market.
Exclusive Content: The platform provides exclusive stories and insights generated by Benzinga reporters, enhancing the trading experience for its users.
Community Engagement: Over 10,000 serious traders are part of the Benzinga Pro community, indicating a robust network for sharing market intelligence.
Market Winning Tools: Benzinga Pro is designed to equip traders with the tools and information necessary to succeed in the markets daily.
Trade with 70% Backtested Accuracy
Analyst Views on CMPO
About CMPO
About the author
CMPO Options Analysis: $20 Put Contract Attractiveness
- Put Contract Appeal: The current bid for the $20.00 put contract is 25 cents, meaning if an investor sells it, they commit to buying CMPO shares at $20.00, effectively lowering their cost basis to $19.75, which is a 21% discount from the current price of $25.20, making it attractive for potential buyers.
- Yield Potential Analysis: Should the put contract expire worthless, it would yield a 1.25% return on cash commitment, or 1.85% annualized, referred to as YieldBoost, highlighting the potential profitability of this option.
- Call Contract Returns: The $30.00 call contract has a current bid of 10 cents; if an investor buys CMPO shares at $25.20 and sells this call, they could achieve a total return of 19.44% if the stock is called away at expiration, indicating significant upside potential.
- Risk Assessment: Current analytics suggest a 69% chance that the $20.00 put contract will expire worthless, while the $30.00 call has a 63% chance of doing the same, emphasizing the need for investors to monitor these probabilities to assess investment risks and rewards.
CompoSecure Stockholders Approve Merger with Husky Technologies
- Shareholder Approval: CompoSecure's shareholders approved the merger with Husky Technologies during a special meeting, which is expected to close in January 2026, potentially opening new growth avenues for the company.
- Regulatory Approvals Pending: The completion of the merger is subject to customary closing conditions, including regulatory approvals, which may affect the timeline and final outcome of the transaction.
- Risk Factors Highlighted: The company noted various risks associated with the merger, including the possibility of not completing the transaction on time or obtaining necessary approvals, which could impact business relationships and financial conditions.
- Forward-Looking Statements: The announcement includes forward-looking statements that emphasize uncertainties regarding the timing of the transaction's completion and expected benefits, reminding investors to consider potential legal and market risks.
Tikvah Management Cuts CompoSecure Stake by 280,000 Shares, Valued at $9.31 Million
- Reduction Update: Tikvah Management reduced its stake in CompoSecure by 280,000 shares in Q3, resulting in an estimated $9.31 million decrease in position value, now holding 1.97 million shares which represent 12.11% of its reportable U.S. equity assets.
- Holding Analysis: Following this reduction, CompoSecure remains the third-largest holding in Tikvah's portfolio, indicating its significance despite market fluctuations and the need for risk management.
- Market Performance: As of Tuesday, CompoSecure shares were priced at $19.37, reflecting a 47% increase over the past year, significantly outperforming the S&P 500's 15% rise, showcasing its strong market position.
- Financial Overview: CompoSecure reported a 13% year-over-year increase in net sales to $120.9 million for Q3, with gross margin expanding to 59% and adjusted EBITDA rising 30% to $47.7 million, as management raised full-year 2025 guidance, indicating ongoing growth potential.
Tikvah Management Cuts 280K Shares of CMPO, Valuation Drops by $9.31M
- Reduction Action: Tikvah Management sold 280,000 shares of CompoSecure in Q3, resulting in a $9.31 million decrease in position value, reflecting a risk management strategy rather than a loss of conviction.
- Current Holdings: As of September 30, Tikvah holds 1.97 million shares of CompoSecure valued at $41.01 million, representing 12.11% of its reportable U.S. equity assets, indicating the stock's significance in its portfolio.
- Performance Metrics: CompoSecure's Q3 net sales rose 13% year-over-year to $120.9 million, with gross margin expanding to 59% and adjusted EBITDA increasing by 30% to $47.7 million, showcasing operational strength.
- Future Guidance: Despite the upcoming business combination with Husky Technologies introducing leverage and integration risks, management has raised full-year 2025 guidance, indicating continued double-digit growth prospects.
Everything You Should Know About CompoSecure (CMPO) Rating Increase to Buy
Zacks Rank Upgrade: CompoSecure, Inc. (CMPO) has been upgraded to a Zacks Rank #2 (Buy), indicating a positive outlook on its earnings estimates, which could lead to increased stock prices.
Earnings Estimate Revisions: The Zacks Consensus Estimate for CompoSecure has risen by 5.1% over the past three months, reflecting analysts' growing confidence in the company's earnings potential.
Investment Strategy: The Zacks rating system, which categorizes stocks based on earnings estimate revisions, suggests that CompoSecure is positioned in the top 20% of stocks, making it a strong candidate for market-beating returns.
Market Performance: Historically, Zacks Rank #1 stocks have generated an average annual return of +25% since 1988, highlighting the effectiveness of the Zacks rating system in identifying profitable investment opportunities.
CompoSecure Analyst Becomes Optimistic as Margins Enhance and Organic Growth Seems Sustainable
Analyst Upgrade: CompoSecure Inc's rating was upgraded from Underweight to Neutral by analyst Reginald Smith, who also increased the price target from $16 to $20 due to healthy margin expansion and organic growth.
Sustainable Growth: Smith noted that the company's margin expansion and reacceleration in organic growth appear sustainable, with management raising their 2025 revenue and EBITDA guidance significantly.
Future Projections: CompoSecure introduced its 2026 guidance, forecasting 10% revenue growth and EBITDA margin expansion of up to 170 basis points, exceeding market expectations.
Stock Performance: At the time of publication, CompoSecure's shares had increased by 0.09% to $20.84, reflecting positive market sentiment following the analyst's report.
CMPO Options Analysis: $20 Put Contract Attractiveness
- Put Contract Appeal: The current bid for the $20.00 put contract is 25 cents, meaning if an investor sells it, they commit to buying CMPO shares at $20.00, effectively lowering their cost basis to $19.75, which is a 21% discount from the current price of $25.20, making it attractive for potential buyers.
- Yield Potential Analysis: Should the put contract expire worthless, it would yield a 1.25% return on cash commitment, or 1.85% annualized, referred to as YieldBoost, highlighting the potential profitability of this option.
- Call Contract Returns: The $30.00 call contract has a current bid of 10 cents; if an investor buys CMPO shares at $25.20 and sells this call, they could achieve a total return of 19.44% if the stock is called away at expiration, indicating significant upside potential.
- Risk Assessment: Current analytics suggest a 69% chance that the $20.00 put contract will expire worthless, while the $30.00 call has a 63% chance of doing the same, emphasizing the need for investors to monitor these probabilities to assess investment risks and rewards.
CompoSecure Stockholders Approve Merger with Husky Technologies
- Shareholder Approval: CompoSecure's shareholders approved the merger with Husky Technologies during a special meeting, which is expected to close in January 2026, potentially opening new growth avenues for the company.
- Regulatory Approvals Pending: The completion of the merger is subject to customary closing conditions, including regulatory approvals, which may affect the timeline and final outcome of the transaction.
- Risk Factors Highlighted: The company noted various risks associated with the merger, including the possibility of not completing the transaction on time or obtaining necessary approvals, which could impact business relationships and financial conditions.
- Forward-Looking Statements: The announcement includes forward-looking statements that emphasize uncertainties regarding the timing of the transaction's completion and expected benefits, reminding investors to consider potential legal and market risks.
Tikvah Management Cuts CompoSecure Stake by 280,000 Shares, Valued at $9.31 Million
- Reduction Update: Tikvah Management reduced its stake in CompoSecure by 280,000 shares in Q3, resulting in an estimated $9.31 million decrease in position value, now holding 1.97 million shares which represent 12.11% of its reportable U.S. equity assets.
- Holding Analysis: Following this reduction, CompoSecure remains the third-largest holding in Tikvah's portfolio, indicating its significance despite market fluctuations and the need for risk management.
- Market Performance: As of Tuesday, CompoSecure shares were priced at $19.37, reflecting a 47% increase over the past year, significantly outperforming the S&P 500's 15% rise, showcasing its strong market position.
- Financial Overview: CompoSecure reported a 13% year-over-year increase in net sales to $120.9 million for Q3, with gross margin expanding to 59% and adjusted EBITDA rising 30% to $47.7 million, as management raised full-year 2025 guidance, indicating ongoing growth potential.
Tikvah Management Cuts 280K Shares of CMPO, Valuation Drops by $9.31M
- Reduction Action: Tikvah Management sold 280,000 shares of CompoSecure in Q3, resulting in a $9.31 million decrease in position value, reflecting a risk management strategy rather than a loss of conviction.
- Current Holdings: As of September 30, Tikvah holds 1.97 million shares of CompoSecure valued at $41.01 million, representing 12.11% of its reportable U.S. equity assets, indicating the stock's significance in its portfolio.
- Performance Metrics: CompoSecure's Q3 net sales rose 13% year-over-year to $120.9 million, with gross margin expanding to 59% and adjusted EBITDA increasing by 30% to $47.7 million, showcasing operational strength.
- Future Guidance: Despite the upcoming business combination with Husky Technologies introducing leverage and integration risks, management has raised full-year 2025 guidance, indicating continued double-digit growth prospects.
Everything You Should Know About CompoSecure (CMPO) Rating Increase to Buy
Zacks Rank Upgrade: CompoSecure, Inc. (CMPO) has been upgraded to a Zacks Rank #2 (Buy), indicating a positive outlook on its earnings estimates, which could lead to increased stock prices.
Earnings Estimate Revisions: The Zacks Consensus Estimate for CompoSecure has risen by 5.1% over the past three months, reflecting analysts' growing confidence in the company's earnings potential.
Investment Strategy: The Zacks rating system, which categorizes stocks based on earnings estimate revisions, suggests that CompoSecure is positioned in the top 20% of stocks, making it a strong candidate for market-beating returns.
Market Performance: Historically, Zacks Rank #1 stocks have generated an average annual return of +25% since 1988, highlighting the effectiveness of the Zacks rating system in identifying profitable investment opportunities.
CompoSecure Analyst Becomes Optimistic as Margins Enhance and Organic Growth Seems Sustainable
Analyst Upgrade: CompoSecure Inc's rating was upgraded from Underweight to Neutral by analyst Reginald Smith, who also increased the price target from $16 to $20 due to healthy margin expansion and organic growth.
Sustainable Growth: Smith noted that the company's margin expansion and reacceleration in organic growth appear sustainable, with management raising their 2025 revenue and EBITDA guidance significantly.
Future Projections: CompoSecure introduced its 2026 guidance, forecasting 10% revenue growth and EBITDA margin expansion of up to 170 basis points, exceeding market expectations.
Stock Performance: At the time of publication, CompoSecure's shares had increased by 0.09% to $20.84, reflecting positive market sentiment following the analyst's report.
